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Research
Arsenic (As) and selenium (Se) share many 
chemical properties and are adjacent on the 
periodic table of elements. The two metal-
loids, however, have marked differences in 
their biological effects (Csanaky and Gregus 
2003). Although toxic at high doses, Se is 
an essential trace element necessary for anti  -
oxidant enzyme activity, thyroid hormone 
metabolism, and immune function and has 
been used in chemo  prevention studies (Zeng 
et al. 2005). In contrast, As has no known 
biological function and displays both acute 
and chronic toxicity. Arsenic-contaminated 
ground  water is a major health concern world-
wide, affecting roughly 140 million people 
in > 70 countries (Kinniburgh and Smedley 
2001; World Bank 2005). Ingestion of inor-
ganic As (InAs) via contaminated drinking 
water is associated with elevated risk of pre-
malignant skin lesions and cancers of the 
skin, lung, bladder, liver, and kidney, as well 
as non  carcinogenic outcomes, including 
cardio  vascular disease and neuro  logi  cal defi-
cits (National Research Council 2001; Tseng 
2008; Wasserman et al. 2004).
In drinking water, As occurs in its inor-
ganic form, either as arsenite (AsIII) or arsenate   
(AsV), the former being the primary form 
found in ground  water in Bangladesh. Once 
ingested, AsIII under  goes oxidative methyla-
tion using S-adenosylmethionine (SAM) as 
the methyl donor, forming mono  methyl-
arsonic acid (MMAV). MMAV can then 
be reduced to mono  methyl  arsonous acid 
(MMAIII), with reducing equivalents pro-
vided by thio  redoxin (Trx) (Thomas et al. 
2004). MMAIII can undergo a second meth-
ylation step to form dimethyl  arsinic acid 
(DMAV), the major metabolite found in 
urine. Population studies have shown that 
individuals having a relatively lower capacity 
to methylate As to DMAV are at greater risk 
for skin cancers (Chen et al. 2003; Hsueh 
et al. 1997; Yu et al. 2000), bladder cancer 
(Huang et al. 2008), and peripheral vascular 
disease (Tseng et al. 2005).
Unlike As, where contaminated drinking 
water is the predominant route of high expo-
sure, most Se in Bangladesh is obtained from 
the diet; the concentrations of Se in drinking 
water in Bangladesh are well below the World 
Health Organization (WHO) guideline of 
10 µg/L (Frisbie et al. 2009). Dietary Se, 
primarily in the form of seleno  methionine, 
under  goes hepatic trans  sulfuration, gener-
ating free seleno  cysteine and metabolically 
active Se. The latter can be incorporated into 
seleno  proteins, including seleno  protein P (a 
Se-rich plasma protein involved in Se trans-
port), glutathione peroxidases, Trx reductase 
(TR), and other seleno  proteins (Burk et al. 
2006). A second pathway results in the pro-
duction of seleno  sugars that are excreted in 
urine (Kobayashi et al. 2002; Kuehnelt et al. 
2007). Although, like As, some Se can be 
metabolized by serial methylation reactions 
(Birringer et al. 2002; Ohta et al. 2009), 
recent evidence indicates that this pathway is 
likely relatively minor (Kuehnelt et al. 2007).
Antagonistic effects between As and Se 
have been well documented since the original 
discovery by Moxon (1938) that cattle could 
be protected from Se toxicity by treatment 
with As. Several studies have indicated that 
As and Se each mutually facilitate excretion 
of the other in bile (Levander 1977). Recent 
work in rabbits indicates that this may occur 
via the formation of a Se–As–glutathione con-
jugate (Gailer et al. 2000), although this has 
not yet been demon  strated in humans. Other 
proposed mechanisms include direct inter-
action and precipitation of As and Se in renal 
cells and effects on cellular signaling, zinc 
finger proteins, and methylation pathways 
(Berry and Galle 1994; Zeng et al. 2005).
The biological interactions between As 
and Se evoke the possibility that Se may influ-
ence the development of As-induced health 
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Ba c k g r o u n d: Global hypomethylation of DNA is thought to constitute an early event in some 
cancers and occurs in response to arsenic (As) exposure and/or selenium (Se) deficiency in both 
in vitro and animal models. In addition, antagonism between As and Se, whereby each reduces   
toxicity of the other, has been well documented in animal models. Se status may therefore modify 
the health effects of As in As-exposed populations.
oB j e c t i v e: The primary objectives of our study were to test the hypothesis that Se deficiency 
is associated with genomic hypo  methylation of lymphocyte DNA and to determine whether Se   
levels are associated with blood As (bAs) and urinary As (uAs) concentrations in adults exposed to 
As-contaminated ground  water in Bangladesh. A secondary objective was to explore the relationships 
between plasma Se and As metabolites.
de s i g n: We assessed plasma Se concentrations, As metabolite profiles in blood and urine, and 
genomic methylation of leukocyte DNA in a cross-sectional study of 287 adults.
re s u l t s: After adjustment for potential confounders, we observed an inverse association between 
Se (micrograms per liter) and genomic DNA methylation (disintegrations per minute per 1-µg/L 
increase in Se): β = 345.6; 95% confidence interval (CI), 59–632. Se concentrations were inversely 
associated with total As concentrations (micrograms per liter) in blood (β = –0.04; 95% CI, –0.08 
to –0.01) and urine (β = –20.1; 95% CI, –29.3 to –10.9). Se levels were negatively associated with 
the percentage of mono  methyl  arsinic acid (β = –0.59; 95% CI, –1.04 to –0.13) and positively asso-
ciated with the percentage of dimethyl  arsinic acid (β = 0.53; 95% CI, 0.04 to 1.01) in blood. 
co n c l u s i o n s: Our results suggest that Se is inversely associated with genomic DNA methyla  tion. 
The under  lying mechanisms and implications of this observation are unclear and warrant further 
investigation. In addition, Se may influence bAs and uAs concentrations, as well as relative propor-
tions of As metabolites in blood.
key w o r d s : arsenic, Bangladesh, DNA methylation, epigenetics, folate, folic acid, selenite, selenium, 
thioredoxin reductase, well water. Environ Health Perspect 119:113–118 (2011).  doi:10.1289/
ehp.1001937 [Online 15 September 2010]Pilsner et al.
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outcomes (Gailer 2009). A recent case–control 
study from our Bangladeshi cohort found that 
blood Se concentrations were inversely associ-
ated with total urinary As (uAs) concentrations 
and with the risk of As-related pre  malignant 
skin lesions (Chen et al. 2007). However, not 
all of the available evidence supports a benefi-
cial effect of Se on As metabolism and toxic-
ity (Geng et al. 2009; Kenyon et al. 1997; 
Styblo and Thomas 2001; Zakharyan et al. 
1995). The effects of dietary Se (i.e., seleno-
methionine) on As metabolism have not previ-
ously been investigated.
Several studies have investigated the 
impact of Se on epigenetic processes. DNA 
methylation, which also requires SAM as the 
methyl donor, involves the covalent addition 
of a methyl group to the 5-carbon of cytosine 
bases located within CpG dinucleo  tides. It is 
an essential epigenetic modification that influ-
ences gene expression, X chromosome inactiva-
tion, and silencing of endogenous retro  viruses. 
In animal models, dietary deficiency of Se 
has been reported to cause genomic hypo-
methylation of liver and colon DNA (Davis 
et al. 2000), whereas supplementation with 
sodium selenite (SeIV) increased DNA methyl-
transferase (DNMT) activity and genomic 
DNA methylation (Davis and Uthus 2003). 
Conversely, in vitro studies in prostate can-
cer cells revealed that SeIV treatment led to 
decreased genomic DNA methylation (Xiang 
et al. 2008).
The primary objectives of this study were 
to test the hypothesis that Se deficiency is 
associated with genomic hypo  methylation of 
lymphocyte DNA and to determine whether 
Se levels were associated with blood As (bAs) 
and uAs concentrations in adults exposed to 
As-contaminated ground  water in Bangladesh. 
A secondary objective was to explore the 
relation  ships between Se and As metabolites.
Materials and Methods
The Nutritional Influences on Arsenic Toxicity 
(NIAT) study was designed to assess the preva-
lence of folate deficiency and hyper  homo-
cysteinemia in Bangladesh (Gamble et al. 
2005a), to determine whether folate nutri-
tional status is associated with methylation of 
As (Gamble et al. 2005b), and to determine 
if folate deficiency and/or As exposure is asso-
ciated with genomic methylation of leuko-
cyte DNA (Pilsner et al. 2007). The NIAT 
study was conducted in collabora  tion with the 
Health Effects of Arsenic Longitudinal Study 
(HEALS), a large prospective cohort study of 
adults exposed to a wide range of water As 
concentrations, from which the present partici-
pants were selected (Ahsan et al. 2006).
The region. The study site is a 25-km2 
region within Araihazar, approximately 30 km 
east of Dhaka, Bangladesh. The variability of 
well-water As concentrations (0.1–860 µg/L) 
in this region offers a unique opportunity to 
study dose–response relationships between As 
exposure and As-related health outcomes. Our 
data on socio  economic status, and data from 
Columbia University’s Center for International 
Earth Science Information Network (2007), 
indicate that this region is not particularly poor 
by Bangladesh standards.
Eligibility criteria and study design. The 
HEALS cohort study originally included 
11,746 men and women between 18 and 
65 years of age who were recruited between 
October 2000 and May 2002 and who con-
tinue to be followed at 2-year intervals. The 
cohort has since been expanded to include 
nearly 20,000 participants. As part of the 
NIAT study, a cross-sectional study of 1,650 of 
the original participants (Gamble et al. 2005a) 
was first conducted to determine the prevalence 
of folate and cobalamin (B12) deficiencies and 
of hyper  homo  cysteinemia, and to identify a 
pool of participants with low plasma folate for 
recruitment into a folic acid inter  vention study. 
The 200 participants enrolled in the folic acid 
supplementation trial were a random sample 
of the 550 participants who fell into the lowest 
tertile of plasma folate from the cross-sectional 
study (Gamble et al. 2005a). Participants were 
excluded if they were pregnant, B12 deficient 
(B12 ≤ 185 pmol/L), or were taking vitamin 
supplements.
For these analyses, we have included base-
line data from 195 participants who completed 
the folic acid intervention study from whom 
high-quality DNA was obtained (Gamble 
et al. 2006, 2007). An additional 100 partici-
pants were recruited from the HEALS cohort 
study in order to capture a wider range of As 
exposure and folate nutritional status. These 
partici  pants were known to have continued 
to drink from the same well for at least the 
past 4 years; we over  sampled participants who 
were drinking from a high-As well such that 
70% were drinking water with > 50 µg As/L. 
Aside from these criteria, these 100 partici-
pants were randomly selected. After excluding 
participants with missing values for plasma Se 
or folate and those with insufficient DNA for 
the measurement of genomic DNA methyla-
tion, 287 Bangladeshi adults were included 
in the present study. Oral informed consent 
was obtained by our Bangladeshi field staff 
physicians, who read an approved assent 
form to the study participants. This study was 
approved by the institutional review boards of 
Columbia Presbyterian Medical Center and 
the Bangladesh Medical Research Council.
Analytic techniques. Sample collection 
and handling. Blood samples for buffy coats, 
plasma total homocysteine, folate, and total 
B12 were obtained by veni  puncture at the 
time of recruitment. Blood was collected 
into heparin-containing Vacutainer tubes, 
which were placed in IsoRack/IsoPack cool 
packs (Brinkmann Instruments, Westbury, 
NY) designed to maintain samples at 0°C for 
6 hr. Within 4 hr, samples were transported 
in hand-carried coolers to our local labora-
tory, situated in our field clinic in Araihazar. 
Samples were centrifuged at 3,000 × g for 
10 min at 4°C, and buffy coat and plasma 
were separated from red cells. Aliquots of 
plasma were stored at –80°C and shipped 
frozen on dry ice to Columbia University 
for analysis. Urine samples were collected 
in 50-mL acid-washed poly  propylene tubes. 
These were kept in portable coolers, frozen at 
–20°C within 4 hr, and shipped on dry ice.
Water As. A survey of all wells in the 
study region assessed water As concentra-
tions of tube wells at each participant’s home 
between January and May 2000 (Van Geen 
et al. 2002). Samples were analyzed at 
Columbia University’s Lamont Doherty 
Earth Observatory by graphite furnace atomic 
absorption (GFAA), which has a detection 
limit of 5 µg/L. Those samples found to have 
non  detectable As concentrations by GFAA 
were subsequently analyzed by inductively 
coupled mass spectrometry (ICP-MS), which 
has a detection limit of 0.1 µg/L (Cheng et al. 
2004).
uAs metabolites and total uAs. Total uAs 
concentrations were measured by GFAA spec-
trometry using an Analyst 600 graphite fur-
nace system (PerkinElmer, Shelton, CT) in the 
Columbia University Trace Metals Core Lab, 
as described previously (Nixon et al. 1991). 
Our laboratory participates in a quality-control 
program for total uAs coordinated by P. Weber 
at the Quebec Toxicology Center (Quebec, 
Canada). During the course of this study, 
intra  class correlation coefficients between our 
laboratory’s values and samples calibrated at 
Weber’s laboratory were 0.99. Urinary crea-
tinine was analyzed using a method based on 
the Jaffe reaction (Slot 1965) and was used to 
correct for hydration status. Arsenic metabo-
lites were speciated using HPLC separa  tion 
of arseno  betaine (AsB), arseno  choline (AsC), 
AsV, AsIII, MMA (MMAIII + MMAV), and 
DMA (DMAV), followed by detection using 
ICP-MS. We calculated the percentages of 
InAs (InAsIII+V; %InAs), MMA (%MMA), 
and DMA (%DMA) after subtracting AsC 
and AsB from the total. The limit of detection 
for each uAs metabolite was 0.1 µg/L. Values 
below the limit of detection were treated as 
zero. The inter    assay coefficients of variation 
(CVs) were 5.8% for total As, 7.8% for AsIII, 
18.3% for AsV, 5.8% for MMA, and 3.1% for 
DMA. The intra  assay CVs were 3.6% for total 
As, 4.2% for AsIII, 10.9% for AsV, 2.3% for 
MMA, and 1.4% for DMA.
Plasma Se. Plasma samples were analyzed   
for Se using an Elan Dynamic Reaction 
Cell (DRC) II ICP-MS equipped with an 
AS 93+ autosampler (PerkinElmer). The Selenium and methylation of arsenic and genomic DNA
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ICP-MS-DRC method for metals in plasma 
was developed according to published pro-
cedures (Pruszkowski et al. 1998), with 
modifications for plasma sample preparation 
developed in our laboratory (Chen et al. 2007). 
Although there are no well-established guide-
lines defining Se deficiency, for the purposes 
of this study we chose to define Se deficiency 
as plasma Se < 70 µg/L. This cutoff is based on 
reports that supplementation with increasing 
doses of seleno  methionine leads to increases in 
the concentration and activity of gluta  thione 
peroxi  dases until the dose–  response relation-
ship reaches a plateau at plasma Se levels 
between 70 and 90 µg/L (Food and Nutrition 
Board 2000; Xia et al. 2005).
bAs metabolites and total bAs. A subset of 
223 subjects had bAs metabolite data available 
from a previous study (Gamble et al. 2007). 
This subset represented individuals with higher 
As exposure in which almost all blood metabo-
lite measurements were above the limit of 
detection of 0.1 µg/L. The inter  assay CVs were 
6.1% for total bAs, 7.5% for AsIII, 11.6% for 
AsV, 5.8% for MMA, and 5.0% for DMA. 
The intra    assay CVs were 4.0% for total bAs, 
2.6% for AsIII, 7.7% for AsV, 6.2% for MMA, 
and 5.5% for DMA. bAs metabolites and total 
bAs were measured as previously described 
(Gamble et al. 2007; Hall et al. 2006; Pilsner 
et al. 2007).
Isolation of leukocyte DNA. Buffy coats 
were transferred to 1 mL RBC Lysis Solution 
(GenomicPrep Blood DNA Isolation 
Kit, cata  log no. 27-5236-01; Amersham 
Biosciences, Piscataway, NJ) and then cen-
trifuged at 16,000 × g for 5 min to separate 
leuko  cytes from contaminating red blood 
cells. Leukocytes were subsequently lysed in 
the presence of a DNA preservative and stored 
at 4°C. Samples were then shipped at 4°C to 
Columbia University, where the isolation of 
leukocyte DNA was completed following the 
manufacturer’s protocol.
Genomic DNA methylation. Genomic 
methylation of leukocyte DNA was determined 
in 500 ng DNA using the methyl acceptance 
assay method of Balaghi and Wagner (1993). 
DNA was incubated with [3H]SAM in the 
presence of the SssI pro  karyotic methylase 
enzyme, which indiscriminately methylates 
all un  methylated CpG sequences. Therefore, 
the ability of DNA to incorporate [3H]methyl 
groups is inversely related to endogenous DNA 
methylation. Briefly, 0.5 µg DNA was incu-
bated with 3 U SssI methylase (New England 
Biolabs, Beverly, MA), 3.8 µM (1.1 µCi) 
3H-labeled SAM (PerkinElmer), EDTA, 
DTT (dithiothreitol), and Tris-HCl (pH 8.2) 
in a 30-µL mixture and incubated for 1 hr at 
37°C. The reaction was terminated on ice, and 
15 µL of the reaction mixture was applied onto 
Whatman DE81 filter paper. The filter was 
washed on a vacuum filtration apparatus three 
times with 5 mL 0.5 M sodium phosphate 
buffer (pH 8.0), followed by 2 mL each of 
70% and 100% ethanol. Dried filters were 
each placed in a vial with 5 mL scintillation 
fluid (Scintisafe; Fisher, Fair Lawn, NJ) and 
were analyzed by a Tri-Carb 2100TR Liquid 
Scintillation Analyzer (Packard Instruments, 
Downers Grove, IL). Each DNA sample was 
processed in duplicate, and each processing 
run included samples for background (reac-
tion mixture with all components except SssI 
enzyme), a hypo  methylation control (HeLa 
cell DNA), and a quality-control sample (DNA 
extracted from a whole-blood sample) to deter-
mine the inter- and intra    assay CVs (1.8% and 
5.3%, respectively). To quantify the amount 
of double-stranded DNA (dsDNA) in each 
reaction, an aliquot of the assayed DNA was 
used to determine DNA concentrations using 
PicoGreen dsDNA Quantitation Reagent 
(Molecular Probes, Eugene, OR). All dis-
integrations per minute (dpm) values were 
expressed per microgram of DNA as quantified 
by PicoGreen.
Plasma folate and B12. Plasma folate and 
total B12 were analyzed by radio  immunoassay 
(Quantaphase II; Bio-Rad Laboratories, 
Richmond CA) as previously reported 
(Gamble et al. 2005a). The intra- and inter-
assay CVs for folate were 3% and 11%, 
respectively, and those for B12 were 4% and 
8%, respectively.
Statistical methods. We calculated 
descriptive statistics for general characteris-
tics as well as for plasma nutrients and uAs 
metabolite concentrations. Paired t-tests were 
used to detect differences between As metabo-
lites in blood and urine. Bivariate associa-
tions between plasma Se and covariates and 
between Se and As variables were examined 
using Spearman correlation coefficients. To 
further examine the associations between 
plasma Se and the outcomes of interest, after 
adjustment for potential confounders, we 
employed linear regression models with the 
main predictor, plasma Se, as a continuous 
variable. We identified potential confound-
ers as variables that were known to be asso-
ciated with the outcomes of interest and 
that were also associated with plasma Se in 
this study sample. These variables included 
age, body mass index (BMI), betel nut use, 
plasma folate, plasma B12, urinary creatinine, 
and water As. We also adjusted for sex and 
smoking, although these variables were not 
associated with plasma Se. All potential con-
founders were modeled as continuous vari-
ables except sex and the variables cigarette 
smoking and betel nut use (both modeled as 
ever/never use). Variables with skewed distri-
butions were log or square root transformed 
before inclusion in linear regression models to 
create approximately normal distributions for 
dependent variables, to improve the linearity 
of the relationship between independent and 
dependent variables, or to reduce the impact 
of extreme values of an independent variable. 
Plasma folate and B12, urinary creatinine, and 
total bAs were log transformed, whereas water 
As was square root transformed.
For the outcome variables in the linear 
regression models that were significantly 
associated with plasma Se as a continuous 
predictor, we then applied linear regression 
models with categorized Se to describe spe-
cific patterns of the associations. We created 
five categories of plasma Se and computed 
covariate-adjusted mean values of the out-
come variables for each category. All of the 
Se-deficient participants were included in the 
first category; the Se-sufficient participants 
were distributed equally among the remaining 
cate  gories (quartiles). 
All analyses were performed using SAS 
(version 9.1; SAS Institute Inc., Cary, NC); 
all statistical tests were two sided with a signifi-
cance level of 0.05.
Results
The characteristics of the study population 
are presented in Table 1. The mean age was 
Table 1. General characteristics of the study sample 
(n = 287).
Variable Mean ± SD (range) or percent
Age (years) 37.9 ± 10.4 (18–66)
Male  48
BMI (kg/m2) 19.8 ± 3.2 (13.3–30.5)
Ever smoking 37.0
Ever betel nut use 33.8
Education (years) 3.3 ± 3.5 (0–16)
Type of housing
Thatched 3.1
Corrugated tin 88.5
Other 8.4
Plasma measures
Plasma Se (µg/L) 87.6 ± 1.8 (45.4–148.8)
Se deficienta 16
Plasma B12 (pmol/L) 276.3 ± 115.1 (86.1–920.0)
B12 deficientb 23
Plasma folate  
  (nmol/L)
8.8 ± 4.3 (3.0–44.7)
Folate deficientc 63
Plasma homo- 
  cysteine (µmol/L)
10.9 ± 5.2 (0.24–49.8)
Water As (µg/L) 113.6 ± 108.0 (0.1–716)
Urinary measures
uAs (µg/L) 172.6 ± 172.4 (8.0–1519.0)
Urinary Cre (mg/dL) 60.5 ± 43.6 (5.6–334.8)
uAs/g Cre 339.0 ± 302.2 (21.0–2018.0)
%InAs 15.1 ± 6.1 (6.0–60.1)
%MMA 12.6 ± 4.2 (3.8–26.9)
%DMA 72.4 ± 7.8 (36.2–87.9)
Blood measuresd
bAs (µg/L) 9.9 ± 6.3 (0.89–30.7)
%InAs 26.3 ± 3.9 (16.2–40.2)
%MMA 40.3 ± 6.3 (15.9–68.5)
%DMA 33.4 ± 6.5 (7.6–48.0)
[3H]Methyl incorp 42,270 ± 3,984 (27,256–56,940)
Abbreviations: Cre, creatinine; incorp, incorporation.
aPlasma Se < 70.0 µg/L. bPlasma cobalamin < 185 pmol/L. 
cPlasma folate < 9 nmol/L. dn = 223. Pilsner et al.
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37.9 years; approximately half of the study 
population was female. The average BMI 
was 19.8, and 41.7% of participants had a 
BMI < 18.5, reflecting the high prevalence of 
under  weight in this population (Centers for 
Disease Control and Prevention 2007). Our 
data show that 89% of participant’s homes 
had corrugated tin roofs, indicative of moder-
ate socio  economic status. Mean plasma Se 
was 87.6 µg/L, and we considered 16% of 
participants Se deficient based on a cutoff 
value of 70 µg/L.
Water As concentrations ranged from 
0.1 to 716 µg/L, with 66% of wells exceed-
ing the Bangladeshi standard of 50 µg/L and 
84% of wells exceeding the WHO standard of 
10 µg/L. [3H]Methyl incorporation (genomic 
DNA methylation) ranged from 27,256 to 
56,940 dpm/µg DNA. In a subset of indi-
viduals (n = 223) for whom bAs data were 
available, the mean bAs concentration was 
9.9 µg/L. We found marked differences in 
mean proportions of As metabolites in blood 
versus urine (DMA, 33.4% vs. 72.4%; MMA, 
40.3% vs. 12.6%; InAs, 26.3% vs. 15.1%; 
paired t-test, p < 0.0001 for all metabolites), 
consistent with the fact that DMA is prefer-
entially excreted in urine.
In the linear regression model presented in 
Table 2, the estimates represent the change in 
mean levels of each outcome variable associated 
with a 1-µg/L increase in plasma Se with and 
without adjusting for age, sex, BMI, smoking, 
betel nut use, plasma folate, plasma B12, uri-
nary creatinine, and water As. Plasma Se was 
positively correlated with [3H]methyl incor-
poration. Because [3H]methyl incorporation 
is inversely related to genomic DNA methyla-
tion, this observation indicates that plasma Se 
concentrations are inversely related to genomic 
DNA methylation. Although we have previ-
ously shown that As exposure is associated with 
increased genomic DNA methylation (Pilsner 
et al. 2007), in the present analyses the asso-
ciation between plasma Se and [3H]methyl 
incorporation was unaltered by the inclusion of 
water As in the regression models.
Plasma Se was inversely associated with 
total uAs with and without adjusting for cova-
riates (Table 2). We found no significant asso-
ciations between plasma Se and the percent 
distribution of uAs metabolites. Increasing 
plasma Se was also associated with a decreas-
ing level of total bAs in unadjusted and 
adjusted linear regression models. In addition, 
plasma Se was inversely associated with blood 
%MMA and positively associated with blood 
%DMA. We found no association between 
plasma Se and blood %InAs.
Adjusted mean values of [3H]methyl incor-
poration and As variables by category of plasma 
Se are presented in Table 3. [3H]Methyl 
incorporation into genomic DNA generally 
increased with increasing plasma Se catego-
ries, although there appeared to be little differ-
ence between the second and third categories. 
Adjusted mean values of total uAs decreased 
with increasing categories of plasma Se. For 
total bAs and blood %MMA, there appeared 
to be a threshold effect; adjusted mean values 
in the first three categories of plasma Se were 
similar and higher than the values in the two 
highest categories. There also appeared to be 
a threshold in the association between plasma 
Se and blood %DMA such that the adjusted 
mean values in the three lowest categories of 
plasma Se were similar and lower than the val-
ues in the two highest categories.
Discussion
In this cross-sectional study of 287 Bangladeshi   
adults, we observed that plasma Se is inversely 
associated with genomic methyla  tion of 
leuko  cyte DNA, with and without adjust-
ment for covariates including plasma folate 
concentrations and water As. In addition, we 
found inverse associations between plasma 
Se and both total uAs and bAs concentra-
tions. Plasma Se was also inversely associated 
with %MMA and positively associated with 
%DMA in blood.
Plasma Se and genomic DNA methylation. 
Our findings, which suggest that plasma Se 
concentrations are inversely related to genomic 
DNA methylation, are contrary to our original 
hypothesis that Se deficiency would be associ-
ated with genomic hypo  methylation of DNA. 
Previous animal and in vitro studies examining 
the influence of Se on DNA methylation have 
been inconsistent. A series of animal stud-
ies indicate that dietary Se deficiency caused 
genomic hypo  methylation of liver and colon 
DNA (Davis et al. 2000; Uthus et al. 2006), 
whereas supplementation with SeIV increased 
DNMT activity and DNA methylation in 
the liver and colon, respectively (Davis and 
Uthus 2003). In vitro studies using Friend 
erythro  leukemic and HCT116 colon carci-
noma cells, however, have shown that SeIV 
exposure caused a decrease in DNMT activ-
ity concomitant with DNA hypo  methylation 
(Cox and Goorha 1986; Fiala et al. 1998). 
Additional data indicate that SeIV treatment 
induced genomic DNA hypo  methylation and 
was associated with the down-regulation of 
DNMT 1 and DNMT 3a expression and his-
tone deacetylase activity in the LNCaP human 
Table 2. Estimated parameters and 95% CIs for associations between increasing plasma Se (µg/L) and 
[3H]methyl incorporation, uAs, and bAs (n = 287).
Unadjusted covariate Adjusted covariate
Outcome variable Coefficient estimate (95% CI) p-Valuea Coefficient estimate (95% CI)b p-Valuea
[3H]Methyl incorporation 395.5 (135.0 to 656.1) 0.003 345.6 (59.1 to 632.2) 0.02
Urinary measures
Total uAs –16.6 (–27.9 to –5.3) 0.004 –20.1 (–29.3 to –10.9) < 0.0001
Urinary percent InAs –0.28 (–0.68 to 0.12) 0.17 0.07 (–0.33 to 0.46) 0.74
Urinary percent MMA 0.20 (–0.08 to 0.48) 0.16 0.18 (–0.10 to 0.46) 0.21
Urinary percent DMA 0.08 (–0.44 to 0.60) 0.76 –0.25 (–0.77 to 0.28) 0.36
Blood measuresc
Log total bAs (µg/L) –0.05 (–0.10 to –0.01) 0.03 –0.04 (–0.08 to –0.01) 0.03
Blood percent InAs 0.07 (–0.22 to 0.36) 0.66 0.06 (–0.24 to 0.36) 0.69
Blood percent MMA –0.57 (–1.05 to –0.10) 0.02 –0.59 (–1.04 to –0.13) 0.01
Blood percent DMA 0.51 (0.02 to 1.00) 0.04 0.53 (0.04 to 1.01) 0.03
ap-Value from a test of the null hypothesis of coefficient equal to zero. bAdjusted for age, sex, BMI, ever smoking, ever 
betel nut use, plasma folate (log), plasma B12 (log), urinary creatinine (log), and water As (square root). cn = 223. Adjusted 
for age, sex, BMI, ever smoking, ever betel nut use, plasma folate (log), plasma B12 (log), and water As (square root). 
Table 3. Adjusteda mean (95% CI) of outcome variables by plasma Se category (n = 287). 
Se category [µg/L; mean (range)]
1 2 3 4 5
Outcome variable 4.54–7.01 (n = 44)  7.02–8.15 (n = 60)  8.16–8.94 (n = 61)  8.95–10.03 (n = 61)  10.04–14.88 (n = 61) 
[3H]Methyl incorporation (dpm/µg DNA) 41,053 (38,909–42,296) 42,273 (41,223–43,324) 42,125 (41,120–43,130) 42,672 (41,641–43,703) 42,988 (41,937–44,039)
Total uAs (µg/L) 221.1 (181.2–261.0) 191.7 (158.0–225.4) 188.6 (156.4–220.8) 158.6 (125.5–191.7) 120.3 (86.6–154.0)
Total bAs (µg/L)b,c,d 8.9 (7.7–10.3) 8.3 (7.3–9.5) 8.8 (7.6–10.2) 7.8 (6.8–9.1) 7.4 (6.4–8.6)
Blood %MMAb,d 41.6 (39.8–43.3) 40.9 (39.3–42.5) 41.5 (39.7–43.2) 38.4 (36.7–40.2) 39.6 (37.8–41.4)
Blood %DMAb,d 32.0 (30.1–33.9) 33.3 (31.5–35.0) 32.6 (30.7–34.5) 34.4 (42.5–36.3) 34.5 (32.5–36.4)
Category 1, Se deficient participants; categories 2–5, quartiles of Se sufficient participants.
aAdjusted for age, sex, BMI, ever smoking, ever betel nut use, plasma folate (log), plasma cobalamin (log), urinary creatinine (log), and water As (square root). bn = 223. cValues are 
geometric means. dAdjusted for age, sex, BMI, ever smoking, ever betel nut use, plasma folate (log), plasma cobalamin (log), and water As (square root). Selenium and methylation of arsenic and genomic DNA
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prostate cancer cell line (Xiang et al. 2008). 
Although speculative, our results are consistent 
with the in vitro assays, suggesting that the 
inverse association between plasma Se con-
centrations and genomic DNA methylation in 
our study could reflect a decrease in DNMT 
expression and/or activity.
Plasma Se and total As concentrations. 
Previous work has suggested that the asso-
ciation between As exposure and clinical 
outcomes may be modified by Se nutritional 
status (Verret et al. 2005). This hypothesis is 
supported by experimental studies indicating 
that As and Se each mutually facilitate biliary 
excretion of the other (Zeng et al. 2005). A 
Se–As–glutathione complex, seleno-bis(S-glu-
tathionyl) arsinium ion, [(GS)2AsSe]−, has 
been detected in biliary excretion of rabbits, 
suggesting that one potential mechanism 
whereby Se intake may reduce the body bur-
den of As is by increasing its loss through 
biliary excretion (Gailer et al. 2000), although 
this complex has not yet been definitively 
identified in humans. In this cross-sectional 
analysis, it is not possible to determine the 
temporal nature of the relationship between 
plasma Se and uAs/bAs or whether this is a 
causal relationship. An additional possibility 
is that As in the environment may adversely 
affect Se nutritional status. For example, a 
recent study reported that high concentrations 
of As in rice in Bangladesh are associated with 
lower levels of Se and other trace minerals in 
rice (Williams et al. 2009).
In the present study, we observed a sig-
nificant inverse association between plasma Se 
and uAs, a finding that is in agreement with 
the results from a previous case–cohort study 
from our study area where higher blood Se 
concentrations were associated with lower uAs 
and reduced risk for As-induced pre  malignant 
skin lesions (Chen et al. 2007). In the pres-
ent study, we observed an inverse association 
between plasma Se and bAs concentrations 
as well, despite the fact that we previously 
detected no association between whole-blood 
Se and bAs concentrations (Chen et al. 2007). 
The explanation for these discrepant findings 
is unclear. One difference between the studies 
is that we measured plasma Se in the present 
study, as opposed to whole-blood Se in the 
previous study.
Plasma Se and As metabolites. Arsenic 
methylation and the toxicity of its metabo-
lites have undergone considerable investiga-
tion in recent years. Compelling evidence 
from experi  mental data suggests that tri  valent 
arsenical intermediates, in particular MMAIII, 
are more toxic than their penta  valent counter-
parts (Petrick et al. 2000, 2001; Styblo et al. 
2000). In agreement with the experi  mental 
data, population-based studies indicate that 
individuals with lower relative proportions of 
urinary DMA (and higher MMA) exhibit a 
greater risk for skin cancers (Chen et al. 2003; 
Hsueh et al. 1997; Yu et al. 2000) and blad-
der cancers (Huang et al. 2008), as well as 
peripheral vascular disease (Tseng et al. 2005). 
These results suggest that individuals who have 
a reduced capacity to fully methylate InAs to 
DMAV, the less toxic metabolite, are at height-
ened risk for As-induced health outcomes.
Antagonism between As and Se whereby 
each reduces the toxicity of the other has long 
been documented (Levander 1977; Moxon 
1938). It is possible that As and Se may cause 
alterations in the biotransformation, distribu-
tion, and excretion of each other (Csanaky and 
Gregus 2003; Kenyon et al. 1997). For exam-
ple, mice fed diets with excess SeIV excreted 
significantly higher proportions of InAs than 
of methylated arsenicals in urine compared 
with mice fed Se-adequate diets (Kenyon et al. 
1997). Experimental studies have shown that 
SeIV exposure reduced the methylation of InAs 
in rat cytosol (Styblo et al. 1996). In a sub-
sequent study, those authors also found SeIV 
to be a potent inhibitor of recombinant arse-
nic methyltransferase (Walton et al. 2003). 
Furthermore, experiments in rat hepato  cytes 
revealed that exposure to both SeIV and AsIII 
decreased the ratio of DMA to MMA, sug-
gesting that the second As methylation step is 
more sensitive to Se than the first (Styblo and 
Thomas 2001). Conversely, in rats injected 
with either AsV or AsIII, SeIV (10 µmol/kg, 
intra  venous) lowered tissue concentrations of 
MMAIII and MMAV but increased the con-
centration of DMAV (Csanaky and Gregus 
2003). However, the effect of supplementation 
with selenomethionine (commonly found in 
food and commercial Se supplements) on As 
methyla  tion has not been tested, and the direct 
relevance of these studies employing inorganic 
forms of Se to the metabolism and toxicity of 
As in humans is unclear.
In the present study, we observed signifi-
cant associations between plasma Se and pro-
portions of As metabolites in blood. Plasma Se 
was associated with lower blood %MMA and 
higher blood %DMA. We observed no signifi-
cant associations between Se and the individual 
proportions of As metabolites in urine. These 
results are not consistent with those of the   
animal studies. This may be due to the use of 
inorganic forms of Se in the animal studies 
and/or to important differences in As metabo-
lism across species (Drobna et al. 2010). A 
potential mechanism by which Se may influ-
ence As metabolism is via the Trx/TR system. 
Trx can provide reducing equivalents for the 
reduction of MMAV to MMAIII, a pre  requisite 
for the generation of DMAV. Se deficiency 
results in decreased activity of TR, a seleno-
protein, thereby limiting the regenera  tion of 
Trx (Hill et al. 1997). Our data are consistent 
with the possibility that Se sufficiency may 
be permissive for the reduction of MMAV to 
MMAIII, consequently facilitating the methyla-
tion of MMAIII to DMAV.
Conclusion
Our results indicate that plasma Se concentra-
tions are inversely related to total bAs and uAs 
concentrations, inversely related to %MMA in 
blood, and positively associated with %DMA 
in blood. Collectively, the data suggest that 
Se may reduce the body burden of As and, 
moreover, may help to reduce concentrations 
of blood MMA, the most toxic metabolite 
in the As methylation pathway. The cross- 
sectional design of this study limits our abil-
ity to determine the temporal nature of our 
observed associations. Ongoing studies in 
Bangladesh are exploring the efficacy of Se 
supplementation in reducing As-induced 
health outcomes. The underlying mechanisms 
and biological implications of the inverse 
association between Se and genomic DNA 
methylation are unclear and warrant further 
investigation.
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